The presented data showed that mTOR complex inhibitors – in parallel reduce tumour growth and migration – have significant inhibitory effect on the productions of both glycolytic lactate and mainly from glutamine sourced 2-HG oncometabolites in vitro and in vivo. Here, MTOR is linked to neoplasm.